Baylor University

TEXAS-DEVELOPED PATENT-FREE COVID-19 VACCINE TECHNOLOGY RECEIVES EMERGENCY USE AUTHORIZATION IN INDONESIA

Retrieved on: 
Friday, September 30, 2022

Itreceived emergency use authorization in Indonesia, as a primary vaccine in adults.

Key Points: 
  • Itreceived emergency use authorization in Indonesia, as a primary vaccine in adults.
  • Indonesia is seeking Halal Certification for the vaccine since no animal cells or products were used in the production of the vaccine.
  • The pharmaceutical company is currently manufacturing Covid-19 primary series vaccine, while booster vaccine is in the clinical trial stage and soon followed by vaccine for children.
  • Bio Farma became a holding company after a merger of three listed state-owned pharmaceutical companies in Indonesia.

iSIGN Media Announces Resignation of a Director

Retrieved on: 
Wednesday, September 28, 2022

Creators of the Smart suite of products, a patented interactive proximity marketing technology, iSIGN enables the delivery of messages to mobile devices in proximity, with real-time reporting and analytics on a variety of metrics.

Key Points: 
  • Creators of the Smart suite of products, a patented interactive proximity marketing technology, iSIGN enables the delivery of messages to mobile devices in proximity, with real-time reporting and analytics on a variety of metrics.
  • The forward-looking statements are not historical facts but reflect iSIGN Medias current expectations regarding future results or events.
  • iSIGN Media assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.
  • 2022 iSIGN Media Solutions Inc. All Rights Reserved.

Connexa Sports Expands its Industry-Leading Collegiate Tennis Technology Footprint with Latest Partnership

Retrieved on: 
Wednesday, September 28, 2022

BALTIMORE, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Connexa Sports Technologies Inc. (NASDAQ: CNXA) (www.connexasports.com), a leading connected sports technology company, is pleased today to announce its latest collegiate tennis partnership. Lubbock Christian University (LCU) is set to become the latest program to add PlaySight’s connected camera technology for live streaming broadcasts and performance video capabilities. PlaySight works with leading programs throughout all conferences and levels of college tennis, and LCU joins other Texas-based programs with PlaySight installed at their home tennis facilities, including the University of Texas, Southwestern University, TCU, Baylor University and more.

Key Points: 
  • PlaySights video tech will drive live streaming and performance tech capabilities at Lubbock Christian University, the latest college tennis partner of Connexa Sports
    BALTIMORE, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Connexa Sports Technologies Inc. (NASDAQ: CNXA) ( www.connexasports.com ), a leading connected sports technology company, is pleased today to announce its latest collegiate tennis partnership.
  • Lubbock Christian University (LCU) is set to become the latest program to add PlaySights connected camera technology for live streaming broadcasts and performance video capabilities.
  • The school has not had a tennis program since the 1981-82 season and will play their home matches at the new Penny Gullo Tennis Center on campus, equipped with PlaySights cutting-edge tennis technology.
  • College tennis is a core focus for us at Connexa, and we are especially thrilled to welcome LCU and bring our technology to their impressive new facility, said Connexa Sports CEO Mike Ballardie.

Duncan NRI at Texas Children's Hospital Accelerates Neurological Research and Therapies with Historic $10M Gift from The Blue Bird Circle

Retrieved on: 
Friday, September 23, 2022

HOUSTON, Sept. 23, 2022 /PRNewswire/ -- The Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital today announced it received a $10 million donation from The Blue Bird Circle.

Key Points: 
  • HOUSTON, Sept. 23, 2022 /PRNewswire/ -- The Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital today announced it received a $10 million donation from The Blue Bird Circle.
  • This historic donation is being made to commemorate the Blue Bird Circle's upcoming centennial anniversary and brings the organization's gifts to Texas Children's to over $25 million which will help advance life-changing neurological research at the Duncan NRI.
  • At Texas Children's Hospital Blue Bird Clinic, Blue Bird volunteers log more than 5,000 hours a year in administrative assistance the equivalent of three full-time employees.
  • The volunteers' time, effort, and donations help support The Blue Bird Circle Clinic for Pediatric Neurology at Texas Children's Hospital.

Geneial Receives $2.3M NIH Grant

Retrieved on: 
Thursday, September 22, 2022

HOUSTON, Sept. 22, 2022 /PRNewswire/ -- Healthtech company Geneial announces a multimillion dollar, non-dilutive award from the National Human Genome Research Institute to fund the development of their secure, decentralized platform.

Key Points: 
  • Geneial will use $2.3M NIH award to build private, decentralized data platform facilitating research of genetic diseases
    Geneial's platform will connect researchers of rare genetic diseases with relevant data while preserving patient privacy.
  • Geneial's platform aims to help researchers leverage large datasets of rare disease populations, incentivizing custodians of biomedical data to grant researchers access to highly targeted biomedical data.
  • "We are honored to have the backing of the NIH and HGSC as we realize our mission of advancing genetic and personalized medicine," shared Adam Hansen, Ph.D., CEO of Geneial and Principal Investigator of this project.
  • We are eager to continue our partnership through the course of this grant and beyond as their offerings expand."

DROWNING PREVENTION RESEARCH SUMMIT KICKS OFF MULTI-YEAR EFFORT TO CHAMPION ADVANCEMENT AND INNOVATION IN DROWNING PREVENTION RESEARCH AND SAFETY

Retrieved on: 
Thursday, September 15, 2022

SAN DIEGO, Sept. 15, 2022 /PRNewswire/ -- On September 13-14, 2022 the National Drowning Prevention Alliance (NDPA.org) hosted the industry's first research summit solely dedicated to water safety and drowning prevention for children and adolescents - a critical issue and the single leading cause of death among children ages 1-4 years old.

Key Points: 
  • "The body of data available for drowning prevention has been historically weak leaving us to use best practices instead of evidence-informed approaches," said Adam Katchmarchi, Ph.D., M.S., Executive Director, NDPA.
  • "Our goal is to change that and bring all stakeholders together to collaborate on a unified research agenda."
  • The Drowning Prevention Research Summit was made possible through the generous funding of the Chuck & Ernestina Kreutzkamp Foundation.
  • The mission of the National Drowning Prevention Alliance is "United, we can prevent the tragedy of drowning."

Tessa Therapeutics Recognized in “Most Promising Off-the-Shelf Therapies” Category at Asia-Pacific Cell & Gene Therapy Excellence Awards 2022

Retrieved on: 
Wednesday, September 14, 2022

SINGAPORE, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced that TT11X, the companys allogeneic off-the-shelf CD30.CAR EBVST cell therapy, has been recognized in the Most Promising Off-the-Shelf Therapies category at the Asia-Pacific Cell & Gene Therapy Excellence Awards (ACGTEA) 2022 .

Key Points: 
  • SINGAPORE, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced that TT11X, the companys allogeneic off-the-shelf CD30.CAR EBVST cell therapy, has been recognized in the Most Promising Off-the-Shelf Therapies category at the Asia-Pacific Cell & Gene Therapy Excellence Awards (ACGTEA) 2022 .
  • The ACGTEA 2022 Awards were held in conjunction with the 6th Cell & Gene Therapy World Asia 2022.
  • Tessa Therapeutics is a clinical-stage biotechnology company developing next-generation cell therapies for the treatment of hematological cancers and solid tumors.
  • Tessa has its global headquarters in Singapore, where the company has built a state of the art, commercial cell therapy manufacturing facility.

MODERN MARKET EATERY INKS FIRST FRANCHISE AGREEMENT

Retrieved on: 
Tuesday, September 13, 2022

DENVER, Sept. 13, 2022 /PRNewswire/ -- Modern Market Eatery, a made-from-scratch fast casual concept, has signed a 41-unit development deal with its first franchise partner, Thrive Restaurant Group. The agreement will expand the brand to 11 new markets, including Wichita and Kansas City, Kansas; Austin, San Antonio and Waco, Texas; Des Moines, Iowa; Charlotte and Raleigh, North Carolina; and Northwest Arkansas.

Key Points: 
  • DENVER, Sept. 13, 2022 /PRNewswire/ -- Modern Market Eatery ,a made-from-scratch fast casual concept, has signed a 41-unit development deal with its first franchise partner, Thrive Restaurant Group .
  • Founded in 2009, Modern Market is a fast casual concept born from the philosophy that faster food can be better food.
  • "Any brand's first franchise partner is extremely special, but what makes Thrive Restaurant Group exceptional is their passion for our shared values," said Rob McColgan, Modern Market co-founder and Modern Restaurant Concepts co-CEO.
  • Modern Restaurant Concepts will be one of the largest fast casual restaurant platforms in North America, with nearly 800 units across three brands, including QDOBA (pending acquisition), Modern Market Eatery and Lemonade.

CCRM Fertility Expands Houston Clinic with Addition of Dr. Beth Zhou

Retrieved on: 
Tuesday, September 13, 2022

HOUSTON, Sept. 13, 2022 /PRNewswire/ -- CCRM Fertility, a global pioneer in fertility treatment, research and science, today announced Dr. Beth Zhou, a reproductive endocrinology and infertility specialist who is board-certified in obstetrics and gynecology, has joined CCRM Houston following her fellowship at University of California, San Diego (UCSD) in La Jolla, Calif. Dr. Zhou is currently accepting new patients.

Key Points: 
  • "CCRM Fertility has always been committed to building, growing and maintaining a team of physicians that share the same passion and attentiveness to personalized fertility care," said Jon Pardew, president and CEO of CCRM Fertility.
  • Dr. Zhou is a native Houstonian and attended the University of Houston where she received her bachelor's degree in biology magna cum laude.
  • Dr. Zhou practices out of the following locations: 929 Gessner Rd., Suite 2300, Houston, TX 77024 and 7400 Fannin, Suite 910, Houston, TX 77054.
  • CCRM Fertility is a global pioneer in fertility treatment, research and science.

Valor CEO Named 2022 Tech Titan Awards Finalist

Retrieved on: 
Wednesday, September 7, 2022

FORT WORTH, Texas, Sept. 7, 2022 /PRNewswire/ -- Valor, an asset management and professional services company specializing in oil and gas mineral rights, is pleased to announce that CEO Joseph DeWoody has been named a finalist for the 2022 Tech Titan Awards, presented by the Technology Association for North Texas. DeWoody is competing to win the title of Emerging Company CEO, which will be announced at an evening gala at the Eisemann Center in Richardson on Thursday, Oct. 27. All finalists for the 2022 Tech Titan Awards will be highlighted in a special ad section of the Dallas Business Journal on Sep. 2, as well as in a special companion publication profile.

Key Points: 
  • FORT WORTH, Texas, Sept. 7, 2022 /PRNewswire/ -- Valor , an asset management and professional services company specializing in oil and gas mineral rights , is pleased to announce that CEO Joseph DeWoody has been named a finalist for the 2022 Tech Titan Awards , presented by the Technology Association for North Texas .
  • All finalists for the 2022 Tech Titan Awards will be highlighted in a special ad section of the Dallas Business Journal on Sep. 2, as well as in a special companion publication profile.
  • "I'm honored to have been selected for an award based on the company's technological prowess," stated Joseph DeWoody, CEO of Valor.
  • Valor has oversight and management of 8.4 million gross acres and 450,000 net royalty acres of mineral and property rights in 32 states.